ZURICH (Reuters) - Johnson & Johnson’s (JNJ.N) Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd (IDIA.S) in an accelerated bookbuilding to commence on Wednesday, the transaction’s bookrunner said.
The sale corresponds to approximately 8.3% of Swiss drugmaker Idorsia’s outstanding ordinary share capital. Goldman Sachs (GS.N) will act as sole bookruner on the sale.
Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields
